Author(s):
Bhavna, Gangotri Rajwade, Dalganjan Behera, Dikendra Dewangan Daleshwar, Deepak Kumar, Gautam, Jitendra Yadav, Sanjay J. Daharwal
Email(s):
jy7288096@gmail.com
DOI:
10.52711/2321-581X.2026.00007
Address:
Bhavna, Gangotri Rajwade, Dalganjan Behera, Dikendra Dewangan Daleshwar, Deepak Kumar, Gautam, Jitendra Yadav*, Sanjay J. Daharwal
University Institute of Pharmacy, Pt. Ravishankar Shukla University, Amanaka, Raipur, CG, 492010, India.
*Corresponding Author
Published In:
Volume - 17,
Issue - 1,
Year - 2026
ABSTRACT:
Itraconazole is an oral triazole antifungal medication used to treat superficial and systemic fungal infections in the mouth, throat, lungs, and nails. Certain brands may not be appropriate for treating nail infections. It may be prepared for topical and systemic use and is well-known for its antimycotic qualities. The goal of this review is to gather the national and international literature on itraconazole estimation in pharmaceutical formulations and bulk, with a focus on UV spectrophotometric and high performance liquid chromatography (HPLC) techniques, High performance thin layer chromatography (HPTLC), Gas chromatography (GC), Gas chromatography-Mass spectroscopy (GC-MS) and Liquid chromatography Mass Spectroscopy (LC-MS). For UV spectroscopy, the important parameters analyzed are ?max and solvent, and for HPLC and HPTLC, the stationary phase, mobile phase, retention period, and column specifications. Validation of an analytical method is a requirement to demonstrate that the method is suitable and appropriate for the intended use, often a prerequisite for analytical purposes. This paper reviews different analytical methods for the determination of itraconazole and its combinations in pharmaceutical drug. It also involves the validation of itraconazole and development of various analytical methods used for different dosage forms.
Cite this article:
Bhavna, Gangotri Rajwade, Dalganjan Behera, Dikendra Dewangan Daleshwar, Deepak Kumar, Gautam, Jitendra Yadav, Sanjay J. Daharwal. Recent Advances in Analytical Techniques for Itraconazole - Brief Review. Research Journal of Engineering and Technology. 2026;17(1):49-7. doi: 10.52711/2321-581X.2026.00007
Cite(Electronic):
Bhavna, Gangotri Rajwade, Dalganjan Behera, Dikendra Dewangan Daleshwar, Deepak Kumar, Gautam, Jitendra Yadav, Sanjay J. Daharwal. Recent Advances in Analytical Techniques for Itraconazole - Brief Review. Research Journal of Engineering and Technology. 2026;17(1):49-7. doi: 10.52711/2321-581X.2026.00007 Available on: https://rjetonline.com/AbstractView.aspx?PID=2026-17-1-7
9. REFERENCES:
1. Mishra K, Behera S, Majhi T, Majhi B, Sankar CG. Itraconazole: A literature review on analytical and bio-analytical methods.
2. Chemical book, CAS database list, itraconazole CAS No. 8465-61-6.
3. National Library of Medicine (IN), itracozaole, pubchem 3793.
4. Rao MK, Ramanjaneyulu KV, Reehana SK, Rao DN, Sujana DL, Kumar JS. Method development and validation of Itraconazole by UV spectrophotometer. World Journal of Pharmaceutical Research. 2014 Oct 7;3(10):777-87.
5. Mishra K, Prasanna KA, Behera SR. Simultaneous estimation of sacubitril and valsartan in bulk and pharmaceutical dosage form by using rp-hplc. Res J Pharmacy Life Sci. 2020 May;1(2):25-32.
6. Parikh SK, Patel AD, Dave JB, Patel CN, Sen DJ. Development and validation of UV spectrophotometric method for estimation of itraconazole bulk drug and pharmaceutical formulation. Int J Drug Dev Res. 2011 Apr;3(2):324-8.
7. Garg AK, Sachdeva RK, Kapoor G. Comparison of crystalline and amorphous carriers to improve the dissolution profile of water insoluble drug itraconazole. Int J Pharm Bio Sci. 2013;4(1):934-48.
8. Prasuna Sundari P, Vijaya Shanthi V. A Review: Analytical Methods for Determination of Itraconazole in Pharmaceutical and Biological samples. International Journal of Chemical and Natural Science. 2013;1(1):21-4.
9. Kukreja T, Saraf S. UV Spectroscopy Analysis for Itraconazole. Journal of Ravishankar University. 2022 Dec 30;35(2):62-7.
10. Nirmal M.K. Shilpa C. Ghudaijial Development and Validation of Simple and Rapid Hplc Method for Determination of Itraconazole In Bulk and Marketed Formulation, 2017; 36-43.
11. Madhavi M, Illendula S. A novel analytical method development and validation for the estimation of itracanazole by UV spectroscopic method.
12. Singh S, Bhandole A, Devendra Lodhi D. Review on analytical methods for estimation of itraconazole in bulk and pharmaceutical dosage form. Int. J. Res. Rev. 2021; 8(5): 30-7.
13. Ladetto MF, Ancarola ME, Lamas DG, Kollrich BA, Cucher MA, Álvarez VA, Glisoni RJ, Castro GR, Islan GA, Cuestas ML. Enhanced antifungal efficacy of clotrimazole and itraconazole delivered via solid lipid nanoparticles for potential otomycosis therapy. Journal of Drug Delivery Science and Technology. 2025 Aug 12:107401.
14. Madgulkar A, Kadam S, Pokharkar V. Studies on formulation development of mucoadhesive sustained release itraconazole tablet using response surface methodology. AAPS Pharmscitech. 2008 Sep;9(3):998-1005.
15. Khandelwal R, Vasava M, Abhirami RB, Karsharma M. Recent advances in triazole synthesis via click chemistry and their pharmacological applications: A review. Bioorganic & Medicinal Chemistry Letters. 2024 Nov 1;112:129927.
16. De Beule K, Van Gestel J. Pharmacology of Itraconazole. Drugs. 2001 Dec;61(Suppl 1):27-37.
17. Downes KJ, Fisher BT, Zane NR. Administration and dosing of systemic antifungal agents in pediatric patients. Paediatric Drugs. 2020 Apr;22(2):165.
18. Bellmann R, Smuszkiewicz P. Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients. Infection. 2017 Dec;45(6):737-79.
19. Nett JE, Andes DR. Antifungal agents: spectrum of activity, pharmacology, and clinical indications. Infectious Disease Clinics. 2016 Mar 1;30(1):51-83.
20. Reinhart JM, Leduc F, Hanzlicek A, Marlo T, Billhymer A, Gochenauer A, Fisher-Cronkhite LL. Therapeutic drug monitoring of itraconazole in treatment of blastomycosis in dogs. Journal of Veterinary Internal Medicine. 2026 Jan;40(1):aalag029.
21. Brüggemann RJ, Alffenaar JW, Blijlevens NM, Billaud EM, Kosterink JG, Verweij PE, Burger DM, Saravolatz LD. Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents. Clinical Infectious Diseases. 2009 May 15;48(10):1441-58.
22. Grant SM, Clissold SP. Itraconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs. 1989 Mar;37(3):310-44.
23. Kuntal K, Singh N, Krishnan SN. Therapeutic drug monitoring in dermatophytosis: Time to reconsider itraconazole and terbinafine exposure targets. Journal of Laboratory Physicians. 2026 Mar 31.
24. Dhoot D, Jain GK, Manjhi M, Kesharwani P, Mahadkar N, Barkate H. Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis. Drugs in Context. 2023 Jan 9;12:2022-8.
25. Panda AK. Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery.
26. Yadav J, Dewangan D, Gupta K, Sahu MK, Verma P, Sahu PK, Sinha S, Sinha A, Daharwal SJ. Analytical Methodologies for Ranolazine estimation: A brief review. Research Journal of Engineering and Technology. 2025 Jul 1;16(3):127-36.
27. Saputra HA, Aji D, Ali BT, Asranudin. Emerging Analytical Techniques for Rare Earth Element Study: Basic Principles and Cutting-Edge Developments. Analytica. 2025 Sep 10;6(3):35.
28. Ghosh S, Nandi S. A Comprehensive Review on UV-Visible Spectroscopy and Its application. Int J All Res Educ Sci Methods. 2024;12:1020-5.
29. Tejaswani, E., Puranik, Sangamesh B., Development and validation of itraconazole by instrumental methods in bulk and marketed formulation, Universal Journal of Pharmacy. 2018, 7(4),7-20.
30. Salunke PA, Ingale K, Ghate PG, Patil SS, Barhate DS. UV visible Spectrophotometric method development and validation of Itraconazole in bulk and capsule formulation. International Journal of Current Research. 2017;9(1):45435-9.
31. Gummadi S, Varanasi S. UV spectrophotometric method development and validation for determination of an antifungal agent in bulk and capsules. Journal of Pharmaceutical Quality Assurance and Quality Control. 2019;1(1).
32. Mishra K, Kumar NH, Begum M, Choudury S, Sankar CG. Analytical techniques for the estimation of itraconazole in capsule dosage form by spectrophotometric method.
33. Sri AN, Kishore L, Bhuvaneshwari M, Harikrishna B. A novel analytical method development and validation of itraconazoleby using UV spectroscopic method. Journal For Innovative Development in Pharmaceutical and Technical Science (JIDPTS). 2025 Aug;8(8).
34. Elmansi H, Roshdy A, Shalan S, El-Brashy A. Combining derivative and synchronous approaches for simultaneous spectrofluorimetric determination of terbinafine and itraconazole. Royal Society Open Science. 2020 Aug 1;7(8).
35. Sanjana NR, Ahmed M, Shetty AS. Development and validation of UV spectrophotometric methods for the simultaneous estimation of itraconazole and terbinafine hydrochloride in bulk drug and pharmaceutical formulations. IJPPR Human. 2020;18(3):486–495.
36. Singh S, Sharma V. Method development and validation for simultaneous estimation of itraconazole and terbinafine HCl in bulk and pharmaceutical dosage form by using UV visible spectroscopy. Int J Pharm Sci Res. 2023;14(8):4193–4201.
37. Chaudhari PR, Patil JK, Jain VH, Pawar SP. Development and Validation of The Uvspectrophotometric and RP-HPLC Method for Simultenious Estimation of Itraconazole and Terbinafine Hydrochloride in Bulk and in Formulation. World J. Pharm. Pharm. Sci. 2019;8:675-702.
38. Shweta, Ms & Somanath, Kulapurath & Agnihotri, Jaya and Taqa, Amer. Development and Validation of UV Spectrophotometric Method for the Simultaneous Estimation of Itraconazole and Amoxicillin in Combined Dosage form using Simultaneous Equation Method in Bulk and Ophthalmic Dosage form. 2023; 12: 2319-7463.
39. Soundarya, G., Rao, P., Venkateswara, Chandrika CH., Praveena, T., Method development and analytical method validation of itraconazole by using UV Visible spectrometry, Indo American Journal of Pharmaceutical Sciences. 2018; 3 (5): 487-491.
40. Jitendra Yadav, Dolly Dewangan, Kamraj, Krity Gupta, Manish Kumar Sahu, Parimal Verma, Prashant Kumar Sahu, Shweta Sinha, Aakanksha Sinha, S. J. Daharwal. A Review of Estimation Techniques for Bifonazole in Pharmaceutical Formulations. International Journal of Technology. 2025; 15(2):51-5. doi: 10.52711/2231-3915.2025.00010.
41. Sarvani Paruchuri SP, Pavani KH. A new development and validated RP-HPLC method for the assay and related substances of Itraconazole in capsule dosage form.
42. Rao, M.Trinadha., Ratna, J.Vijaya., Rao, Y. Shrinivas., Kumar, T.Hemant., Development and validation of RP-HPLC method for the determination of itraconazole in bulk and capsule dosage form, International Journal of Pharmaceutical Sciences Review and Research. 2015, 31(2), 221-225.
43. Kasagić Vujanović IR, Malenović A, Jovanović M, Rakić T, Jančić Stojanović BI, Ivanović D. Chemometrically assissted optimization and validation of RP-HPLC method for the analysis of itraconazole and its impurities. Acta Pharmaceutica. 2013 Jun 30;63(2):159-73.
44. Kumudhavalli MV. Isocratic RP-HPLC, UV method development and validation of Itraconazole in capsule dosage form. International Journal of Pharmaceutical Sciences and Research. 2011 Dec 1;2(12):3269.
45. Thangabalan B, Salomi M, Sunitha N, Babu SM. Development of validated RP-HPLC method for the estimation of Itraconazole in pure and pharmaceutical dosage form. Asian J. Pharm. Ana. 2013 Oct;3(4):119-23.
46. Yunoos M, Bharadwaj C, Sandeep V, Rajesh S, Krishna C. Determination of itraconazole in bulk and capsule dosage form by a validated isocratic RP-HPLC method. Asian Journal of Research in Chemistry. 2015 Apr 1;8(4):236.
47. Gupta M, Rajput M. Development and validation of RP-HPLC method for quantitation of itraconazole in tablet dosage form. International Journal of Pharma Research & Review. 2015 Nov;4(11):23-9.
48. Kasekar, M.Nirmal., Godiyal, C.Shilpa., Jadhav, R.Kisan., Kadam, J.Vilassao., Development and validation of simple rapid HPLC method for the determination of itraconazole in bulk and marketed formulation. Der Pharmacia Letter, 2017 9(10), 36-43.
49. Mannem, Babu., Durga, Kesana., Babu, Surendra., Development and validation of RP-HPLC method for cis-bromo benzoate determination in itraconazole API (active pharmaceutical ingredient) and its pharmaceutical dosage form. International Journal of Applied Chemistry. 2017,4(3), 34 40.
50. Wharton M, Geary M, Sweetman P, Curtin L, O’Connor N. Rapid liquid chromatographic determination of itraconazole and its production impurities. Journal of Chromatographic Science. 2014 Mar 1;52(3):187-94.
51. Srividya R. Simultaneous determination of itraconazole and terbinafine in pharmaceutical dosage forms by RP-HPLC. World Journal of Pharmaceutical Sciences. 2025 Jun 5.
52. Choi H, Yim J, Cha JH, Kim J, Kim KJ, Nam M, Nam MH, Lee CK, Cho Y, Yun SG. HPLC-MS/MS Method Validation for Antifungal Agents in Human Serum in Clinical Application. Clinical Laboratory. 2023 Sep 1;69(9).
53. Lande R. Development and Validation of Itraconazole capsule by using HPLC.
54. Singh Y, Bhardwaj A. New Rp-Hplc method development and validation for the estimation of antifungal drug itraconazole in itraconazole loaded invasomes gel. Journal of Advanced Scientific Research. 2021 Nov 30;12(04):263-7.
55. Damle, S., Choudhari, M., Singhvi, G., Saha, R.N. and Dubey, S.K. Development and Validation of Reverse‐Phase High‐Performance Liquid Chromatography Method for Estimation of Itraconazole through Hydroxypropyl Methylcellulose Acetate Succinate based Polymeric Films using Quality by Design principles. Separation Science Plus. 2021; 4(11-12): 388-400.
56. Vidushi Y, Meenakshi B, Bharkatiya M. A review on HPLC method development and validation. Res J Life Sci, Bioinform, Pharm Chem Sci. 2017;2(6):178.
57. Parikh SK, Dave JB, Patel CN, Ramalingan B. Stability-indicating high-performance thin-layer chromatographic method for analysis of itraconazole in bulk drug and in pharmaceutical dosage form. Pharmaceutical Methods. 2011 Apr 1;2(2):88-94.
58. Mirza MA, Talegaonkar S, Iqbal Z. Quantitative analysis of itraconazole in bulk, marketed, and nano formulation by validated, stability indicating high performance thin layer chromatography. Journal of Liquid Chromatography and Related Technologies. 2012 Jun 1; 35(11): 1459-80.
59. Meshram D, Bagade S. High Performance Thin Layer Chromatographic Estimation of Itraconazole in Capsules. J. of Pharma. Res. 2007; 6: 205-7.
60. Patni AK, Monif T, Khuroo AH, Tiwary AK. Validated Liquid chromatography tandem mass spectrometric method for quantification of Itraconazole and Hydroxy Itraconazole in human plasma for pharmacokinetic study. Der Pharmacia Lettre. 2010; 2(2): 41-53.
61. Bharathi DV, Hotha KK, Sagar PV, Kumar SS, Reddy PR, Naidu A, Mullangi R. Development and validation of a highly sensitive and robust LC–MS/MS with electrospray ionization method for simultaneous quantitation of itraconazole and hydroxyitraconazole in human plasma: application to a bioequivalence study. Journal of Chromatography B. 2008 Jun 1;868(1-2):70-6.
62. Haq KU, Kaushal C, Kumar N. Itraconazole Method Validation in plasma using LC-MS/MS: An addendum to the full validation. Int. J. Pharmacol. Pharm. Sci. 2015;2:42-9.
63. Babu MD, Kishore ME, Babu KS. Development and validation of a headspace gas chromatographic method for the determination of methyl bromide content in itraconazole API. International Letters of Chemistry, Physics and Astronomy. 2015 Jan 1;59:160.
64. Babu MD, Babu SK, Kishore K. Development and validation of a GC-MS with SIM method for the determination of trace levels of methane sulfonyl chloride as an impurity in Itraconazole API. J. Anal. Bioanal. Tech. 2016;7:2.
65. Durga Babu M, Surendrababu K, Kishore M. Development and Validation of a Gas Chromatography Mass Specrometry with Selected Ion Monitoring Method for The Determination of Trace Levels of Methane Sulfonyl Chloride as an Impurity in Itraconazole Active Pharmaceutical Ingradients. Asian Journal of Pharmaceutical Clinical Research. 2016; 9(5): 403-407.